| Date | Form | Description | Docs | XBRL | Pages |
| 07/21/17 | 8-K | Current report filing |
|
3 | |
| 07/12/17 | 8-K | Current report filing |
|
3 | |
| 06/22/17 | SC 13D/A | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities |
|
5 | |
| 06/22/17 | SC 13D/A | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities |
|
5 | |
| 06/06/17 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 06/05/17 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 06/05/17 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 06/02/17 | 8-K | Current report filing |
|
28 | |
| 05/26/17 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
32 |
| 05/17/17 | 8-K | Current report filing |
|
30 |
Latest News & Events
Anixa Biosciences Announces Dr. Jose Conejo-Garcia will Keynote the South Carolina Clinical & Translational Research Institute 2026 Retreat
Read More...Anixa Biosciences Reports Encouraging Patient Survival Observations in Ovarian Cancer CAR-T Trial; Achieves Regulatory Approval Enabling Major Dose Escalation
Read More...Anixa Biosciences Secures United States Adopted Names Council Approval of Non-Proprietary Name for its CAR-T Therapy, a Key Step Toward Future Commercialization
Read More...